Novo Holdings have established a strategic relationship and made an LP investment in Pureos Bioventures II, a Life Sciences venture fund managed by Pureos Bioventures. Pureos Bioventures, based in Switzerland,  invests in Seed and Series A biopharmaceutical companies with a particular focus on the DACH region.